APA-Zitierstil (7. Ausg.)

Jackson, D., Wechsler, M. E., Jackson, D. J., Bernstein, D., Korn, S., Pfeffer, P. E., . . . Pavord, I. D. (2024). Twice-yearly Depemokimab in severe asthma with an eosinophilic phenotype. The New England journal of medicine, 391(24), . https://doi.org/10.1056/NEJMoa2406673

Chicago-Zitierstil (17. Ausg.)

Jackson, David, et al. "Twice-yearly Depemokimab in Severe Asthma with an Eosinophilic Phenotype." The New England Journal of Medicine 391, no. 24 (2024). https://doi.org/10.1056/NEJMoa2406673.

MLA-Zitierstil (9. Ausg.)

Jackson, David, et al. "Twice-yearly Depemokimab in Severe Asthma with an Eosinophilic Phenotype." The New England Journal of Medicine, vol. 391, no. 24, 2024, https://doi.org/10.1056/NEJMoa2406673.